3 no-brainer UK shares to buy in February

Here’s my list of three shares to buy in February. I think all of them offer me wealth-enhancing opportunities despite their fallen share prices.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

British union jack flag and Parliament house at city of Westminster in the background

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Sometimes the market offers up what seem like no-brainer buys to me. Here’s three UK shares to buy that I think fit into that category right now.

A former penny stock

hVIVO (LSE HVO) recently moved from the penny stock realm to the world of small-caps. This was after the shares rose 41% in January. However, that still leaves them down 57% since reaching an all-time high of 38p back in April 2021.

The company is a world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge trials. These clinical trials involve exposing healthy volunteers to the pathogen a vaccine is being trialed to protect against. The firm runs these challenge studies at its specialist facility in London.

So why the recent turnaround in the stock? Well, hVIVO is signing larger contracts with global biopharma clients, resulting in it recently raising its guidance. Full-year revenue for 2022 was £50.6m, a 30% year-on-year increase.

Importantly, this is profitable growth, with the company expecting full-year EBITDA margins of at least 17%. Plus, the group’s order book has swelled to record levels, rising 60% year on year to £76m. This represents a six-fold increase since 2020.

With its shares at 16p and a market cap of £110m, I think hVIVO has the potential to march higher from here. Despite the inherent riskiness of human challenge trials, I’ve been loading up on the stock.

Rising defence budgets

The shocking reality of war again in Europe sent many defence stocks soaring last year. Indeed, BAE Systems rocketed 54% in 2022, making it the best-performing stock across the whole FTSE 100. However, shares in electronic warfare specialist Chemring Group (LSE: CHG) are down 18% in six months.

As a reminder, the company develops advanced technology solutions, including products used to deceive radar, sonar, and other detection systems. Military aircraft can use its technology to fool ground-to-air missiles. It also sells products to detect biological and chemical weapons.

Needless to say, this stuff has been in high demand lately. The group’s full-year revenue to 31 October increased 13% year on year to £442.8m. Its underlying pre-tax profit rose 12% to £62.5m. Noticeably though, Chemring’s order book has expanded significantly, rising 30% year on year to £650.9m.

One risk here is customer concentration, as around 80% of the company’s sales are from the UK and US. Any massive cuts to military spending in either country could hurt sales. Yet I doubt that’ll happen. Global military spending is forecast to rise by 8.6% this year, according to data provider Janes.

So the stock looks like a no-brainer buy to me. That’s why I recently added it to my own portfolio.

Income

My final share to buy is Warehouse REIT, the real estate investment trust that focuses on ‘last mile’ warehouses. The stock plummeted 41% last year, with investors fearing that a recession and higher interest rates could threaten rental income and the value of its property portfolio. These risks haven’t gone away.

However, new lettings have increased its portfolio occupancy rate to 93.3%, which looks solid to me. The stock has a forward dividend yield of 6.2%.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has positions in BAE Systems, Chemring Group Plc, Warehouse REIT Plc, and hVIVO Plc. The Motley Fool UK has recommended Warehouse REIT Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Penny stocks to consider buying while their prices are this cheap

Some of the penny stocks I've been watching have already climbed above the 100p level. But I see potential in…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

Revealed! One of the hottest growth, value, and dividend shares to buy today

This high-dividend, low-cost company is also one of the London stock market's most exciting growth shares, writes Royston Wild.

Read more »

Investing Articles

£20,000 in savings? Here’s how I’d target a £2,219 monthly passive income with FTSE 100 shares

Investing in FTSE 100 shares can be a great way to turn a regular investment into a life-changing passive income…

Read more »

Investing Articles

These are the most popular 2024 Stocks and Shares ISA picks so far

After a few tough years, it looks like the 2024 Stocks and Shares ISA season is getting off to a…

Read more »

Investing Articles

This FTSE 100 ETF may be the simplest way to become a stock market millionaire

Ben McPoland considers one very straightforward stock market investing strategy that could lead to a million-pound portfolio.

Read more »

Investing Articles

I’d buy 11,220 Legal & General shares for £200 a month in passive income

Our writer considers how much money investors would have to put into Legal & General (LON:LGEN) shares to target £2,400…

Read more »

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

These 2 magnificent FTSE 250 shares are on sale right now!

These FTSE 250 companies still look cheap, despite recent share price gains. Here's why our writer Royston Wild thinks they’re…

Read more »

Blue NIO sports car in Oslo showroom
Growth Shares

Down 36% in 2024, how low could NIO shares go?

The electric vehicle sector has seen some tremendous volatility in recent years, but what does the future hold for NIO…

Read more »